Alzheimer’s disease (AD) begins to alter and damage the brain years — even decades — before symptoms appear, making early identification of AD risk paramount to slowing its progression.
In a new study published online in the September 9, 2019 issue of the Neurobiology of Aging, scientists at University of California San Diego School of Medicine say that, with further developments, measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increased genetic risk for AD before cognitive decline begins.
In recent years, researchers investigating the pathology of AD have primarily directed their attention at two causative or contributory factors: the accumulation of protein plaques in the brain called amyloid-beta and tangles of a protein called tau. Both have been linked to damaging and killing neurons, resulting in progressive cognitive dysfunction.
The new study focuses on pupillary responses which are driven by the locus coeruleus (LC), a cluster of neurons in the brainstem involved in regulating arousal and also modulating cognitive function. Tau is the earliest occurring known biomarker for AD; it first appears in the LC; and it is more strongly associated with cognition than amyloid-beta. The study was led by first author William S. Kremen, PhD, and senior author Carol E. Franz, PhD, both professors of psychiatry and co-directors of the Center for Behavior Genetics of Aging at UC San Diego School of Medicine.
The LC drives pupillary response — the changing diameter of the eyes’ pupils — during cognitive tasks. (Pupils get bigger the more difficult the brain task.) In previously published work, the researchers had reported that adults with mild cognitive impairment, often a precursor to AD, displayed greater pupil dilation and cognitive effort than cognitively normal individuals, even if both groups produced equivalent results. Critically, in the latest paper, the scientists link pupillary dilation responses with identified AD risk genes.
“Given the evidence linking pupillary responses, LC and tau and the association between pupillary response and AD polygenic risk scores (an aggregate accounting of factors to determine an individual’s inherited AD risk), these results are proof-of-concept that measuring pupillary response during cognitive tasks could be another screening tool to detect Alzheimer’s before symptom appear,” said Kremen.
The Latest on: Diagnosing Alzheimer’s
via Google News
The Latest on: Diagnosing Alzheimer’s
- Worcester researchers study link between microbiome and Alzheimer's diseaseon October 7, 2020 at 1:54 pm
Researchers in Worcester are taking a closer look at Alzheimer's disease by studying the bacteria in the gut."Our main theory on this is that your gut microbiome influences your systemic immune ...
- Progress is on the horizon in Alzheimer's: but will patients get access?on October 7, 2020 at 10:47 am
In March, the FDA will release the eagerly-anticipated results of its priority review of aducanumab -- Biogen and Eisai's investigational treatment for Alzheimer's disease. If approved, this could be ...
- Dana Goldman: Progress is on the horizon in Alzheimer's. But will patients get access?on October 7, 2020 at 10:35 am
The panel was moderated by Schaeffer Center Director Dana Goldman. Cohen noted several barriers to a diagnosis of Alzheimer’s, including difficulty in recognizing the difference between the disease ...
- Are You Afraid Of Alzheimer's?on October 7, 2020 at 10:11 am
You could also cut your risk of depression or anxiety by 11 percent. Hearing aids will help you stay socially connected, which may be the one most important step you can take for your overall health, ...
- Woman diagnosed with Alzheimer’s at 22 says she’s just grateful she can still readon October 7, 2020 at 9:04 am
Amanda Rushing is beginning to lose her speech and mobility - but says it is a relief that she can still indulge her favorite hobby, reading ...
- Video: Woman who was diagnosed with Alzheimer's at age 22 gives interview at age 42on October 7, 2020 at 6:53 am
A woman who was diagnosed with early onset Alzheimer's at just age 22, gives her second interview at age 42. The disease has a long history in her family, taking her aunt, uncle, and father too soon ...
- Two years later: KFOR checks in with young Oklahoma woman battles early onset Alzheimer’son October 6, 2020 at 8:56 pm
News 4 first visited Amanda Rushing in 2018, when Amanda, then 40, shared what it was like to be battling Alzheimer’s at such a young age. And over the past two years, Anna says she’s ...
- $5.5 million NIH grant supports new tests to diagnose dementias earlier and easieron October 6, 2020 at 9:40 am
Researchers at Case Western Reserve University School of Medicine seek to optimize emerging methods of diagnosing two common neurodegenerative diseases -- dementia with Lewy bodies and Parkinson's ...
- India's skydive for her parents after Alzheimer's diagnosison October 6, 2020 at 6:38 am
After both her parents were diagnosed with Alzheimer's, a woman from Malpas decided she wanted to take a leap of faith in her efforts to fundraise for future research.
- Meet the 2 Women Behind the Stamp to Stamp Out Alzheimer’son October 5, 2020 at 8:44 am
Both women are celebrating today’s rebirth of their Alzheimer’s Disease Research stamp. Known as a “semipostal,” it’s a special kind of fundraising postage stamp costing 65 cents (a dime more than a ...
via Bing News